Medicamental therapy of otitis externa and otitis media

Okovityĭ S.V.

Poliklinika #91;
Sankt-Peterburgskaia gosudarstvennaia khimiko-farmatsevticheskaia akademiia, Sankt-Peterburg

Ivkin D.Iu.

Kafedra farmakologii Sankt-Peterburgskoĭ gosudarstvennoĭ khimiko-farmatsevticheskoĭ akademii

Malygin S.V.

Kafedra farmakologii Sankt-Peterburgskoĭ gosudarstvennoĭ khimiko-farmatsevticheskoĭ akademii

Medicamental therapy of otitis externa and otitis media

Authors:

Okovityĭ S.V., Ivkin D.Iu., Malygin S.V.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2012;77(1): 52‑56

Downloaded: 240

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Okovityĭ SV, Ivkin DIu, Malygin SV. Medicamental therapy of otitis externa and otitis media. Russian Bulletin of Otorhinolaryngology. 2012;77(1):52‑56. (In Russ.)

Подписка 2025 (Russian Bulletin of Otorhinolaryngology)

Close metadata

Recommended articles:

Vestibular rehabilitation for peripheral vestibular hypofunction: an interdisciplinary consensus. Russian Bulletin of Otorhinolaryngology. 2024;(1):52-63

The objective of the present work was to analyse the available pharmaceutical products used for treatment of otitis media. The rational application of these medications makes it possible to eliminate rapidly a variety of etiological factors, reduce the severity of inflammation, and improve the quality of life of the patients. One of the approaches to the achievement of these goals for the patients with otitis externa and otitis media consists of the use of combined preparations containing antibacterial, antimycotic, anti-inflammatory and analgetic components. Candibiotic is a four-components drug composed of chloramphenicol, clotrimazol, beclomethasone and lidocaine. The advantages of Candibiotic include high therapeutic efficacy due to its ethiotropic and pathogenetic activity and safety as its components do not have ototoxicity in the case of local application).

Keywords:

otitis externa

otitis media

medicamental therapy

Candibiotic

Authors:

Okovityĭ S.V.

Poliklinika #91;
Sankt-Peterburgskaia gosudarstvennaia khimiko-farmatsevticheskaia akademiia, Sankt-Peterburg

Ivkin D.Iu.

Kafedra farmakologii Sankt-Peterburgskoĭ gosudarstvennoĭ khimiko-farmatsevticheskoĭ akademii

Malygin S.V.

Kafedra farmakologii Sankt-Peterburgskoĭ gosudarstvennoĭ khimiko-farmatsevticheskoĭ akademii

List of references:

Zavarzin B.A., Anikin I.A. Kandibiotik v lechenii ostrykh srednikh i naruzhnykh otitov. Ros otorinolar 2011; 2: 146-149.
Rosenfeld R.M., Brown L., Cannon R.C. et al. Clinical practice guideline: Acute otitis externa. Otolaryngology 2006; 134: 4-23.
Grossan M. Cerumen removal - current challenges. Ear Nose Throat J 1998; 77: 541-548.
Blomgren K. Acute external otitis. Duodecim 2011; 127: 13: 1331-1334.
Jackman A., Ward R., April M., Bent J. Topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol 2005; 69: 857-860.
Hopsu E., Närkiö-Mäkelä M., Silvola J. How and when is topical treatment applied into the ear? Duodecim 2011; 127: 14: 1470-1480.
Nicholas R.O., Berry V., Hunter P.A., Kelly J.A. The antifungal activity of mupirocin. J Antimicrob Chemother 1999; 43: 4: 579-582.
Kravchenko D.V. Rezul'taty obsledovaniya i lecheniya bol'nykh ostrym gnoinym srednim otitom. Nov otorinolar i logopatol 2002; 1: 77-78.
Nikolaev V.V. Opyt obshchego i lokal'nogo primeneniya antigomotoksicheskikh preparatov v otorinolaringologii. Biolog Med 1997; 1: 34-35.
Ovchinnikov A.Yu. Opyt ispol'zovaniya preparata kandibiotik v otorinolaringologicheskoi praktike. Ros otorinolar 2004; 4: 101-103.
Sox C.M. Trends in otitis media treatment failure and relapse. Pediatrics 2008; 121: 674-679.
Kosyakov S.Ya., Lopatin A.S. Ostryi, zatyanuvshiisya i retsidiviruyushchii srednii otit: vybor lecheniya na rasput'e. Consilium Medicum 2004; 4: 270-274.
Turovskii A.B., Kryukov A.I. Ostroe vospalenie naruzhnogo i srednego ukha. Consilium Medicum 2000; 8: 323-325.
Chonmaitree T. Acute otitis media is not a pure bacterial disease. Clin Infect Dis 2006; 43: 11: 1423-1425.
Uhari M., Mantyssari K., Niemela M. Meta-analitic review of the risk factors for acute otitis media. Clin Infect Dis 1996; 22: 1079-1083.
De Castro Junior T. Acute Otitis Media. Jux Fed of ORL (JFOS) 1998; 17-23.
Kratkii spravochnik po antimikrobnoi terapii. Pod red. R.S. Kozlova. Smolensk: MAKMAKh; 2009.
Senfordskii spravochnik: antimikrobnaya terapiya. M: EKSMO 2009.
Little P. Delayed prescribing - a sensible approach to the management of acute otitis media. JAMA 2006; 296: 10: 1290-1291.
Yanov Yu.K., Ryazantsev S.V. Etiopatogeneticheskaya terapiya ostrykh srednikh otitov. Consilium medicum 2005; 4: 290-297.
Bodmer D., Brors D., Pak K. et al. Gentamicin - indused hair cell death is not dependent on the apoptosis receptor Fas. Laryngoscope 2003; 113: 3: 452-456.
Acuin J., Smith A., Mackenzie I. Interventions for chronic suppurative otitis media. Cochrane Review. CD000473. In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
Prevention of hearing impairment from chronic otitis media. Report of a WHO/CIBA Foundation Workshop held at The CIBA Foundation, London, UK, 19-21 Nov 1996. Geneva: World Health Organization, 1998. (WHO/PDH/98.4) (accessed Jan 2003). V internete: www.who.int/pbd/pdh/Docs/COM-Cover-sum.html
Kitsera A.O., Kitsera A.A. Ototoksicheskoe deistvie antibiotikov. Zhіnochii lіkar 2008; 5: 40.
Haynes D.S., Rutka J., Hawke M., Roland P.S. Ototoxicity of ototopical drops an update. Otolaryngol Clin N Am 2007; 40: 669-683.
Pontes Z.B., Silva A.D., Lima Ede O. et al. Otomycosis: a retrospective study. Braz J Otorhinolaryngol 2009; 75: 3: 367-370.
Garashchenko T.I., Denisova O.A., Kotov R.V. Startovaya antibiotikoterapiya pri ostrom srednem otite i ostrom sinusite u detei. Vestn otorinolar 2005; 3: 82-83.
Froom J., Culpepper L. Diagnosis and antibiotic treatment ofacute otitis media, report from international primary care networa. Br Med J 1990; 300: 582-588.

Close metadata